Y-Biologics, Inc. (KOSDAQ:338840)
South Korea flag South Korea · Delayed Price · Currency is KRW
22,800
-900 (-3.80%)
At close: Feb 6, 2026

Y-Biologics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
346,060113,678230,299---
Market Cap Growth
187.59%-50.64%----
Enterprise Value
322,935102,035230,749---
Last Close Price
22800.007690.0015600.00---
PS Ratio
95.8119.7366.19---
PB Ratio
25.135.798.86---
P/TBV Ratio
25.816.279.94---
EV/Sales Ratio
89.4117.7166.33---
Debt / Equity Ratio
1.390.040.110.250.210.16
Asset Turnover
0.100.220.120.120.110.16
Quick Ratio
1.1510.587.391.602.913.35
Current Ratio
1.1610.737.481.703.203.78
Return on Equity (ROE)
-49.24%-28.23%-90.84%-77.73%-54.50%-40.90%
Return on Assets (ROA)
-14.21%-20.30%-21.27%-34.84%-24.67%-11.53%
Return on Capital Employed (ROCE)
-59.20%-41.10%-37.00%-90.60%-54.20%-20.30%
Earnings Yield
-2.52%-5.67%-9.06%---
FCF Yield
-1.65%-6.16%-3.39%---
Buyback Yield / Dilution
-3.46%-19.30%-1.87%-1.01%-21.93%-5.25%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.